U.S. States Expand COVID-19 Vaccine Access Amid FDA Limits

Several states and health organizations are taking steps to improve access to the 2025-2026 COVID-19 vaccines despite federal limitations. New Jersey’s Department of Banking & Insurance urges carriers to cover COVID-19 vaccinations for everyone aged six months and older without prescription requirements, supported by the Murphy administration's executive directive allowing pharmacists to administer vaccines without prescriptions. Virginia has issued a statewide standing order permitting pharmacists to vaccinate seniors and adults with underlying conditions without a prescription, anticipating updated CDC recommendations after a forthcoming ACIP meeting. Kaiser Permanente is also offering the vaccine to all members six months and older at no cost, departing from FDA guidelines that restrict eligibility to seniors and high-risk individuals. However, in San Diego County, logistical challenges such as delayed vaccine availability, insurance complications, and reliance on pending ACIP recommendations are causing difficulties for residents seeking the vaccine. These varied approaches reflect ongoing efforts to balance public health demands with federal regulatory shifts during the 2025-2026 respiratory illness season.